Insider Trading activities at Aradigm Corp (ARDM)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aradigm Corp (ARDM) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aradigm Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1013238.

Total stock buying since 2016: $0.
Total stock sales since 2016: $36,418.
Total stock option exercises since 2016: $0.


1 insider reported insider trading activities at Aradigm Corp (ARDM):
Insider trading activities of Froehlich Juergen Kurt

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Aradigm Corp (ARDM).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2018 0 $0 17,317 $26,393 0 $0
2017 0 $0 3,765 $5,685 0 $0
2016 0 $0 756 $4,340 0 $0

Table 2. Monthly summary of insider trading at Aradigm Corp (ARDM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-09 0 $0 306 $367 0 $0
2018-01 0 $0 17,011 $26,026 0 $0
2017-04 0 $0 3,765 $5,685 0 $0
2016-10 0 $0 423 $2,859 0 $0
2016-06 0 $0 333 $1,481 0 $0

Table 3. Detailed insider trading at Aradigm Corp (ARDM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-09-19 Froehlich Juergen Kurt (Chief Medical Officer) Sale 306 1.20 367
2018-01-29 Froehlich Juergen Kurt (Chief Medical Officer) Sale 17,011 1.53 26,026
2017-04-04 Froehlich Juergen Kurt (Chief Medical Officer) Sale 3,765 1.51 5,685
2016-10-04 Froehlich Juergen Kurt (Chief Medical Officer) Sale 423 6.76 2,859
2016-06-21 Froehlich Juergen Kurt (Chief Medical Officer) Sale 333 4.45 1,481

Insider trading activities including stock purchases, stock sales, and option exercises of ARDM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aradigm Corp (symbol ARDM, CIK number 1013238) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.